More Immunotherapy Options Approved for Lung Cancer

The FDA has approved atezolizumab and expanded the approval of pembrolizumab for some patients with non-small cell lung cancer. Source...

NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued Progress

Dr. Julia Rowland, director of NCI’s Office of Cancer Survivorship, on the office’s 20th anniversary and efforts to ensure continued...

Device Uses Cancer Cells' Mass to Predict Response to Treatment

Scientists have designed a device that measures the mass of single cancer cells to predict how cells respond to drug...

Why Vitamin D or Lack of It May Be Contributing to or Causing Your Health Issues

I’m sure by now everybody has heard of Vitamin D and how important it is for our overall health! If...

Prescription Subsidies Reduce Breast Cancer Treatment Disparities

A new study has found that subsidies for prescription drugs can improve the use of adjuvant therapy in women with...

FDA Approves Nivolumab for Head and Neck Cancer

The FDA has approved nivolumab for squamous cell carcinoma of the head and neck that has progressed during chemotherapy with...

FDA Approves New Use for Daratumumab in Multiple Myeloma

The FDA has approved daratumumab, in combination with either of two other standard therapies, in patients with multiple myeloma whose...

Single Tumor Cells Reveal Clues to Biology of Multiple Myeloma

A study suggests that individual tumor cells circulating in the blood of patients with multiple myeloma may be a new...

For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain

Researchers have found that duloxetine (Cymbalta®), a drug most commonly used to treat depression, may also reduce joint pain caused...